These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26672992)

  • 61. Guest Editorial: Strengthening NCD prevention through risk factor surveillance.
    Bonita R
    Glob Health Action; 2009 Sep; 2():. PubMed ID: 20027247
    [No Abstract]   [Full Text] [Related]  

  • 62. [Scheme of the Chinese chronic non-communicable disease and risk factor surveillance].
    Wang LM; Zhang M; Li YC; Huang ZJ; Deng Q; Zhao ZP; Li C; Zhou MG; Wang LH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Feb; 52(2):191-194. PubMed ID: 29429277
    [No Abstract]   [Full Text] [Related]  

  • 63. Year in Review: Communicable Disease Surveillance, 2000.
    N S W Public Health Bull; 2001 Sep; 12(9):247-254. PubMed ID: 12105551
    [No Abstract]   [Full Text] [Related]  

  • 64. Indirect estimation of the prevalence of type 2 diabetes mellitus in the sub-population of Tehran: using non-laboratory risk-score models in Iran.
    Azizpour Y; Asgari S; Yaseri M; Fotouhi A; Akbarpour S
    BMC Public Health; 2024 Oct; 24(1):2797. PubMed ID: 39395938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monitoring the sleep health of adults: a scoping review of routine national surveillance systems.
    Way JAH; Ucak S; Martinez CA; Sutherland K; Cook KM; Cistulli PA; Bin YS
    Sleep Adv; 2024; 5(1):zpae062. PubMed ID: 39314745
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surveillance system integration: reporting the results of a global multicountry survey.
    Carter ED; Stewart DE; Rees EE; Bezuidenhoudt JE; Ng V; Lynes S; Desenclos JC; Pyone T; Lee ACK
    Public Health; 2024 Jun; 231():31-38. PubMed ID: 38603977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Surveillance of Noncommunicable Diseases: Opportunities in the Era of Big Data.
    Li P; Ma L; Liu J; Zhang L
    Health Data Sci; 2022; 2022():9893703. PubMed ID: 38487489
    [No Abstract]   [Full Text] [Related]  

  • 68. Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019.
    Rashidi MM; Saeedi Moghaddam S; Azadnajafabad S; Mohammadi E; Khalaji A; Malekpour MR; Keykhaei M; Rezaei N; Esfahani Z; Rezaei N; ; Mokdad AH; Murray CJL; Naghavi M; Larijani B; Farzadfar F
    Clin Kidney J; 2024 Jan; 17(1):sfad279. PubMed ID: 38288035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Reference evaluations for estimating prevalence, incidence, and mortality of public health relevant diseases based on routine data].
    Krause L; Reitzle L; Hess S; Ziese T; Adewuyi D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Feb; 67(2):139-148. PubMed ID: 38189861
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diabetes Surveillance in Germany - Background, concept and prospects.
    Gabrys L; Schmidt C; Heidemann C; Baumert J; Du Y; Paprott R; Teti A; Wolf IK; Ziese T; Scheidt-Nave C
    J Health Monit; 2017 Mar; 2(1):83-95. PubMed ID: 37168685
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The global epidemiology of SLE: narrowing the knowledge gaps.
    Barber MRW; Falasinnu T; Ramsey-Goldman R; Clarke AE
    Rheumatology (Oxford); 2023 Mar; 62(Suppl 1):i4-i9. PubMed ID: 36987602
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Putting non-communicable disease data to work in Vietnam: an investigation of community health surveillance capacity.
    Nguyen TNT; Nguyen TTT; Tran BQ; Pham CT; Perry KE; Haregu T; Oldenburg B; Kowal P
    BMC Public Health; 2023 Feb; 23(1):321. PubMed ID: 36788519
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selecting and defining indicators for diabetes surveillance in Germany.
    Gabrys L; Heidemann C; Schmidt C; Baumert J; Teti A; Du Y; Paprott R; Ziese T; Banzer W; Böhme M; Borrmann B; Busse R; Freitag M; Hagen B; Holl R; Icks A; Kaltheuner M; Koch K; Kümmel S; Kuhn J; Kuß O; Laux G; Schubert I; Szecsenyi J; Uebel T; Zahn D; Scheidt-Nave C
    J Health Monit; 2018 Jun; 3(Suppl 3):3-21. PubMed ID: 35586543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Establishing a Mental Health Surveillance in Germany: Development of a framework concept and indicator set.
    Thom J; Mauz E; Peitz D; Kersjes C; Aichberger M; Baumeister H; Bramesfeld A; Daszkowski J; Eichhorn T; Gaebel W; Härter M; Jacobi F; Kuhn J; Lindert J; Margraf J; Melchior H; Meyer-Lindenberg A; Nebe A; Orpana H; Peth J; Reininghaus U; Riedel-Heller S; Rose U; Schomerus G; Schuler D; von Rüden U; Hölling H
    J Health Monit; 2021 Dec; 6(4):34-63. PubMed ID: 35146320
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Public Health Surveillance Systems in the Eastern Mediterranean Region: Bibliometric Analysis of Scientific Literature.
    Saad RK; Al Nsour M; Khader Y; Al Gunaid M
    JMIR Public Health Surveill; 2021 Nov; 7(11):e32639. PubMed ID: 34723831
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 'Hybrid Survey' approach to non-communicable disease surveillance in the US-Affiliated Pacific Islands.
    Cash HL; De Jesus S; Durand AM; Tin STW; Shelton D; Robles R; Mendiola AR; Brikul S; Ipil M; Murphy M; Hunt LSS; Nielsen Lesa F; Sigrah CA; Waguk R; Abraham D; Kapiriel SF; Camacho J; Chutaro E
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34706881
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Worldwide surveillance of self-reported sitting time: a scoping review.
    Mclaughlin M; Atkin AJ; Starr L; Hall A; Wolfenden L; Sutherland R; Wiggers J; Ramirez A; Hallal P; Pratt M; Lynch BM; Wijndaele K;
    Int J Behav Nutr Phys Act; 2020 Sep; 17(1):111. PubMed ID: 32883294
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Health reporting as part of public health surveillance: the example of diabetes].
    Reitzle L; Paprott R; Färber F; Heidemann C; Schmidt C; Thamm R; Scheidt-Nave C; Ziese T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Sep; 63(9):1099-1107. PubMed ID: 32813075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic Solutions for Addressing Non-Communicable Diseases in Low- and Middle-Income Countries.
    Ganju A; Goulart AC; Ray A; Majumdar A; Jeffers BW; Llamosa G; Cañizares H; Ramos-Cañizares IJ; Fadhil I; Subramaniam K; Lim LL; El Bizri L; Ramesh M; Guilford M; Ali R; Devi RD; Malik RA; Potkar S; Wang YP
    J Multidiscip Healthc; 2020; 13():693-707. PubMed ID: 32801732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Strengthening Primary Health-Care Services to Help Prevent and Control Long-Term (Chronic) Non-Communicable Diseases in Low- and Middle-Income Countries.
    Haque M; Islam T; Rahman NAA; McKimm J; Abdullah A; Dhingra S
    Risk Manag Healthc Policy; 2020; 13():409-426. PubMed ID: 32547272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.